期刊文献+

乳腺癌细胞蛋白质O-GlcNAc糖基化水平与紫杉醇抗肿瘤作用的关系研究

Relationship of protein O-GlcNAcylation levels with antitumor effect of Taxol in breast cancer
下载PDF
导出
摘要 目的研究紫杉醇对乳腺瘤细胞蛋白质O-Glc NAc糖基化水平的影响及其机制,探讨蛋白质O-Glc NAc糖基化水平变化对紫杉醇抗肿瘤活性的影响。方法使用Western blot检测紫杉醇对乳腺癌细胞蛋白质O-Glc NAc糖基化水平及多种相关酶蛋白表达水平的影响;RT-q PCR检测紫杉醇对N-乙酰氨基葡萄糖苷酶(β-N-acetylglucosaminidase,OGA)和N-乙酰氨基葡萄糖转移酶(β-N-acetylglucosaminyltrans-fevase,OGT)mRNA水平的影响;采用OGA/OGT抑制剂PUGNAc/alloxan改变蛋白质O-Glc NAc糖基化水平,磺基罗丹明B法测定紫杉醇对肿瘤细胞增殖的影响。结果紫杉醇可诱导乳腺癌细胞MDA-MB-231蛋白质O-Glc NAc糖基化水平升高(P<0.05),且具有时间和浓度依赖性;紫杉醇还可同时诱导OGA和OGT mRNA和蛋白水平的升高(P<0.05),且具有浓度依赖性;采用OGA的抑制剂PUGNAc提高蛋白质O-Glc NAc糖基化水平后,细胞对紫杉醇的敏感性升高;采用OGT的抑制剂alloxan降低蛋白质O-Glc NAc糖基化水平后,细胞对紫杉醇的敏感性降低。结论紫杉醇可诱导蛋白质O-Glc NAc糖基化水平升高,蛋白质O-Glc NAc糖基化水平的改变也会影响乳腺癌细胞对紫杉醇的药物敏感性。 Objective To study effect of Taxol on protein O-GlcNAcylation levels and investigate whether protein O-GlcNAcylation levels can affect the sensitivity of breast cancer cells to Taxol.Methods Western blot analysis was performed to examine protein O-GlcNAcylation levels and the expression of enzymes related to O-GlcNAcylation biosynthesis in Taxol treated breast cancer cells.RT-qPCR was used to analyze the effects of Taxol on OGA and OGT mRNA expression in cancer cells.The sulforhodamine B colorimetric assay was used to determine the effect of alteration of protein O-GlcNAcylation on the anti-proliferation of Taxol in breast cancer cells by adding OGA inhibitor and OGT inhibitor, respectively.Results Taxol treatment enhanced protein O-GlcNAcylation levels in dose-and time-dependent manners in breast cancer cell MDA-MB-231 ( P 〈0.05 ) .Taxol increased the mRNA levels of OGT and OGA after MDA-MB-231 cells were treated for 24 h(P〈0.05).As OGA inhibitors increased protein O-GlcNAcylation levels, the sensitivity of MDA-MB-231 to Taxol was increased.As OGT inhibitor decreased protein O-GlcNAcylation levels, the sensitivity of MDA-MB-231 to Taxol was reduced.Conclusion Taxol treatment can enhance protein O-GlcNAcylation levels and the changes of O-GlcNAcylation levels alter the sensitivity of breast cancer cell MDA-MB-231 to Taxol.
出处 《中国生化药物杂志》 CAS 2015年第5期1-5,共5页 Chinese Journal of Biochemical Pharmaceutics
基金 国家自然科学基金(81272208) 山东省自然科学基金(ZR2009CM046)
关键词 O-GlcNAc糖基化 紫杉醇 N-乙酰氨基葡萄糖苷酶 N-乙酰氨基葡萄糖转移酶 O-Glycosylation Taxol β-N-acetylglucosaminidase β-N-acetylglucosaminyltransferase
  • 相关文献

参考文献15

  • 1Bond MR, Hanover JA. A little sugar goes a long way: the cell biology of O-GlcNAc [ J ]. J Cell Biol,2015,208 ( 7 ) : 869 -880.
  • 2deQueiroz RM, Carvalho E, Dias WB. O-GleNAcylation: the sweet side of the cancer[ J]. Front Oncol,2014,4:00132.
  • 3Ma Z, Vosseller K. O-GlcNAc in cancer biology [ J ]. Amino Acids, 2013,45 (4) :719-733.
  • 4Christiansen MN, Chik J, Lee L, et al. Cell surface protein glycosylation in cancer[ J ]. Proteomics ,2014,14 (4-5) :525-546.
  • 5Lange T, Samatov TR, Tonevitsky AG, et al. Importance of altered glycoprotein-boundN- andO-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells [ J ]. Carbohydr Res, 2014,389 : 39-45.
  • 6Bull C ,Stoel MA, denBrok MH, et al. Sialie acids sweeten a tumor's life[ J]. Caneer Res,2014,74(12) :3199-3204.
  • 7Park JJ,Lee M. Increasing the et 2,6 sialylation of glyeoproteins may contribute to metastatic spread and therapeutic resistance in eoloreetal ea [J]. Gut Li 2013,7(6) :629-641.
  • 8Park J J, Yi JY, JinYB, et al. Sialylation of epidermal growth faetor receptor regulates receptor activity and ehemosensitivity to gefitinib in eolon cancer eells [ J ]. Bioehem Pharmacol, 2012,83 ( 7 ) : 849 -857.
  • 9Croci DO, Cediani JP, Dalotto-Moreno T, et al. Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors[ J]. Cell,2014,156(4) :744-758.
  • 10Han YY, Liu HY, Han DJ, et al. Role of glycasylation in the antieancer activity of antibacterial peptides against breast cancer cells [ J ]. Bioehem Pharmaeol,2013, 86(9) :1254-1262.

二级参考文献72

  • 1Moremen KW, Tiemeyer M, Naim AV. Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol, 2012, 13(7): 448-62.
  • 2Casey PJ. Protein lipidation in cell signaling. Science, 1995, 268(5208): 221-5.
  • 3Zachara NE, Hart GW. The emerging significance of O-GlcNAc in cellular regulation. Chem Rev, 2002, 102(2): 431-8.
  • 4Blom N, Sicheritz-Ponten T, Gupta R, et al. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics, 2004, 4(6): 1633-49.
  • 5Wells L, Whelan SA, Hart GW. O-GlcNAc: a regulatory post-translational modification. Biochem Biophys Res Commun, 2003, 302(3): 435-41.
  • 6Slawson C, Copeland RJ, Hart GW. O-GlcNAc signaling: a metabolic link between diabetes and cancer? Trends Biochem Sci, 2010, 35(10): 547-55.
  • 7Hart GW, Copeland ILl. Glycomics hits the big time. Cell,2010, 143(5): 672-6.
  • 8Wang Z, Gucek M, Hart GW. Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc. Proc Natl Acad Sci USA, 2008, 105(37): 13793-8.
  • 9Copeland RJ, Bullen JW, Hart GW. Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am J Physiol Endocrinol Metab, 2008, 295(1): E17-28.
  • 10Manning G, Whyte DB, Martinez R, et al. The protein kinase complement of the human genome. Science, 2002, 298(5600): 1912-34.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部